Patent · US Expired

Prostate cancer assays and related methods

US6352834B1 · kind B1 · utility

1Cited by
4References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 17, 1998
Grant dateMar 5, 2002
Priority date
Expiry dateJul 17, 2018

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S435/962
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention includes a method for stimulating increased PSA production by prostate cancer cells, comprising the steps of reducing the amount of iron available to the prostate cancer cells; and causing increased PSA production. In another aspects of the present invention, there are provided prostate cancer diagnostic kits comprising a first container containing an iron chelator; and second container containing a free-PSA-specific antibody, wherein the free-PSA-specific antibody is detectable. Also provided as part of the present invention are methods for diagnosing prostate cancer in a human, comprising reducing the amount of available iron in the human, and subsequently testing PSA levels.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.